These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29188804)

  • 1. Device therapy: Interatrial shunt device for HFpEF.
    Lim GB
    Nat Rev Cardiol; 2018 Jan; 15(1):4. PubMed ID: 29188804
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
    Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.
    Kosowski M; Kübler P; Kołodziej A; Krakowiak B; Kustrzycka-Kratochwil D; Sławin J; Sokolski M; Biegus J; Zymliński R; Banasiak W; Ponikowski P; Reczuch K
    Kardiol Pol; 2017; 75(8):736-741. PubMed ID: 28541594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
    Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
    Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
    Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
    Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [InterAtrial Shunt Device in diastolic heart failure].
    Hasenfuß G; Jacobshagen C
    Internist (Berl); 2018 Oct; 59(10):1054-1062. PubMed ID: 30194481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interatrial Shunt Devices.
    Salah HM; Baratto C; Yaranov DM; Rommel KP; Achanta S; Caravita S; Reddy Vasanthu VK; Fudim M
    Heart Fail Clin; 2024 Jan; 20(1):61-69. PubMed ID: 37953022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
    Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
    Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Treatment Effect of Transcatheter Interatrial Shunt Device Using Heart Failure Event Rates.
    McCaw ZR; Kim DH; Wei LJ
    JAMA Cardiol; 2019 Mar; 4(3):299. PubMed ID: 30785598
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating Treatment Effect of Transcatheter Interatrial Shunt Device Using Heart Failure Event Rates-Reply.
    Shah SJ; Feldman T; Massaro J
    JAMA Cardiol; 2019 Mar; 4(3):299-300. PubMed ID: 30785592
    [No Abstract]   [Full Text] [Related]  

  • 12. Device Therapy for Heart Failure with Preserved Ejection Fraction.
    Salah HM; Levin AP; Fudim M
    Cardiol Clin; 2022 Nov; 40(4):507-515. PubMed ID: 36210134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.
    Rodés-Cabau J; Bernier M; Amat-Santos IJ; Ben Gal T; Nombela-Franco L; García Del Blanco B; Kerner A; Bergeron S; Del Trigo M; Pibarot P; Shkurovich S; Eigler N; Abraham WT
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2300-2310. PubMed ID: 30391390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Decompression Using Unidirectional Left-to-Right Interatrial Shunt: Initial Experience in Treating Symptomatic Heart Failure With Preserved Ejection Fraction With the W-Wave Device.
    Amat-Santos IJ; Del Trigo M; Bergeron S; Pibarot P; Altisent O; Campelo-Parada F; Puri R; Verheye S; Keren G; Katzenellenbogen R; Rozenfeld E; Abraham WT; Bernier M; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 May; 8(6):870-872. PubMed ID: 25999114
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.
    De Rosa R; Schranz D
    Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction.
    von Roeder M; Rommel KP; Kowallick JT; Blazek S; Besler C; Fengler K; Lotz J; Hasenfuß G; Lücke C; Gutberlet M; Schuler G; Schuster A; Lurz P
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28360259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sHunt for better breathing in heart failure with preserved ejection fraction.
    Borlaug BA
    Eur J Heart Fail; 2014 Jul; 16(7):709-11. PubMed ID: 24920438
    [No Abstract]   [Full Text] [Related]  

  • 19. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction.
    Paitazoglou C; Özdemir R; Pfister R; Bergmann MW; Bartunek J; Kilic T; Lauten A; Schmeisser A; Zoghi M; Anker S; Sievert H; Mahfoud F
    EuroIntervention; 2019 Aug; 15(5):403-410. PubMed ID: 31130524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment With an Interatrial Shunt in Heart Failure: 1-Year Outcomes of the PRELIEVE Study.
    Paitazoglou C; Bergmann MW; Kilicaslan B; Kilic T; Bartunek J; Pfister R; Iliadis C; Kaya EB; Ozdemir R
    JACC Heart Fail; 2024 Mar; 12(3):591-594. PubMed ID: 38180430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.